Hostname: page-component-848d4c4894-x24gv Total loading time: 0 Render date: 2024-05-05T16:50:15.047Z Has data issue: false hasContentIssue false
  • English
  • Français

Stimuli-Responsive Hydrogels Based on the Genetically Engineered Proteins: Actuation, Drug Delivery and Mechanical Characterization

Published online by Cambridge University Press:  01 February 2011

Elizabeth A. Moschou ,
Nitin Chopra ,
Santoshkumar L. Khatwani ,
Jason D. Ehrick ,
Sapna K. Deo ,
Leonidas G. Bachas  and
Sylvia Daunert
Elizabeth A. Moschou
Affiliation:
daunert@uky.edu, University of Kentucky, Chemistry, 800 rose street, lexington, KY, 40506, United States
Nitin Chopra
Affiliation:
nchop2@gmail.com, University of Kentucky, Department of Chemistry, Lexington, KY, 40506, United States
Santoshkumar L. Khatwani
Affiliation:
santoshkhatwani@yahoo.com, University of Kentucky, Department of Chemistry, Lexington, KY, 40506, United States
Jason D. Ehrick
Affiliation:
jdehrick@hotmail.com, University of Kentucky, Department of Chemistry, Lexington, KY, 40506, United States
Sapna K. Deo
Affiliation:
deo@chem.iupui.edu, University of Kentucky, Department of Chemistry, Lexington, KY, 40506, United States
Leonidas G. Bachas
Affiliation:
bachas@uky.edu, University of Kentucky, Department of Chemistry, Lexington, KY, 40506, United States
Sylvia Daunert
Affiliation:
daunert@uky.edu, University of Kentucky, Department of Chemistry, Lexington, KY, 40506, United States
Get access

Abstract

Herein, we describe a biomimetic approach aimed at the development of synthetic biohybrid materials inspired by nature's sensing and actuating mechanism of action. The biomaterials are based on the incorporation of the hinge-motion binding protein calmodulin (CaM) and its low affinity ligand phenothiazine (TAPP) within the bulk of an acrylamide hydrogel network, which is accomplished through covalent binding. At the initial state and in the presence of Ca2+ ions, CaM interacts with TAPP creating chemical (non-covalent) cross-links within the bulk of the hydrogel, forcing the material to assume a constrictive configuration. Upon the removal of Ca2+, CaM releases TAPP, breaking the non-covalent cross-links within the bulk of the hydrogel and letting the material relax into a swollen state. The same type of effect is observed when a higher affinity ligand for CaM, like chlorpromazine (CPZ), is employed. In the presence of CPZ, the protein releases TAPP and binds CPZ, allowing the biomaterial to swell into a relaxed state. This swelling response of the biomaterial is reversible, and is directly related to the levels of CPZ used. The sensing and subsequent actuating mechanism of the CaM-based stimuli-sensitive hydrogels makes them suitable for a variety of applications, including sensing, mechanical actuation, high-throughput screening, and drug delivery. Additionally, it is shown that the CaM-based stimuli-sensitive hydrogels developed present unique mechanical properties, suitable for integration within microfluidics and MEMS structures. It is envisioned that these biomaterials will find a number of applications in a variety of fields, including drug delivery.

Keywords

biomaterialmicroelectro-mechanical (MEMS)polymer
Type
Research Article
Information
MRS Online Proceedings Library (OPL) , Volume 952: Symposium F – Integrated Nanosensors , 2006 , 0952-F05-02
Copyright
Copyright © Materials Research Society 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Soong, R. K., Bachand, G. D., Neves, H. P., Olkhovets, A. G., Craighead, H. G., Montemagno, C. D., Science 290, 1555–1558 (2000).Google Scholar
2. Liu, H., Schmidt, J. J., Bachand, G. D., Rizk, S. S., Looger, L. L., Hellinga, H. W., Montemagno, C. D., Nature Mater. 1, 173–177 (2002).Google Scholar
3. Kroger, N., Deutzmann, R., Sumper, M., Science 286, 1129–1132 (1999).Google Scholar
4. Brott, L. L., Naik, R. R., Pikas, D. J., Kirkpatrick, S. M., Tomlin, D. W., Whitlock, P. W., Clarson, S. J., Stone, M. O., Nature 413, 291–293 (2001).Google Scholar
5. Meyer, D. E., Chilkoti, A., Nature Biotechnol. 17, 1112–1115 (1999).Google Scholar
6. Knoblauch, M., Noll, G. A., Müller, T., Prüfer, D., Schneider-Hüther, I., Scharner, D., Van Bel, A. J. E., Peters, W. S., Nature Mater. 2, 600–603 (2003).Google Scholar
7. Miyata, T., Uragami, T., Nakamae, K., Adv. Drug Deliv. Rev. 54, 79–98 (2002).Google Scholar
8. Petka, W. A., Harden, J. L., McGrath, K. P., Wirtz, D., Tirrell, D. A., Science 281, 389–392 (1998).Google Scholar
9. Miyata, T., Asami, N., Uragami, T., Nature 399, 766–769 (1999).Google Scholar
10. Deo, S. K., Moschou, E. A., Peteu, S. F., Bachas, L. G., Daunert, S., Eisenhardt, P. E., Madou, M. J., Anal. Chem. 76, 207A–213A (2003).Google Scholar
11. Ehrick, J. D., Deo, S. K., Browning, T. W., Bachas, L. G., Madou, M. J., Daunert, S., Nature Mat. 4,198–302 (2005).Google Scholar
12. Kopecek, J., Nature 417, 388–391 (2002).Google Scholar
13. Johnson, B., Beebe, D. J., Crone, W. C., Mater. Sci. Eng., C 24, 575–581 (2004).Google Scholar